The House
Markets Edge · Huang GoodmanVirginia Beach · Atlantic coast · since 1997
On the wire

Markets Edge

Issued Friday, May 1, 2026 · 06:00 UTC Edition 8/day editions · 5 desks From the chopped neck
7
On the wire
$0.003per impression · vs Meta 0.007 CPM
8 monthsretention in hand · vs Meta 0.8 seconds
200brands you already own · Nike · YETI · Patagonia
Onenamed-account desk · by introduction
Ranked by the pour ISABELLA'S ISLAY HENRI IV MACALLAN 1926 LOUIS XIII PAPPY 23 JOHNNIE BLUE WELL POUR
Also crossing the wire
Showing 7 stories
ISABELLA'S ISLAY Capital Markets May 1, 2:01 AM EDT
Pershing Square
Gotrade ↗

Ackman prices $5B combined IPO on NYSE in dual-listing structure

Pershing Square priced a combined $5 billion IPO on the New York Stock Exchange, marking a significant capital markets event.

ReadingWhen a $5B dual-listing prices cleanly, it signals institutional conviction in concentrated strategy. The next activist will cite this.
WatchSecondary market pricing over the first 30 days. If the spread tightens, other alternative managers will file within 60 days.
Read full analysis → Original ↗
capital marketsipopershing squarealternative managers
HENRI IV M&A Intelligence May 1, 2:01 AM EDT
Lazard
Reuters ↗

Lazard acquires Campbell Lutyens for $575M in private capital advisory play

Lazard completed the acquisition of Campbell Lutyens, a private capital advisory firm, for $575 million, creating a new private capital advisory unit.

ReadingAdvisory consolidation in private capital is accelerating. Firms with founder risk now have a clear exit price point.
WatchWhich other independent advisors will announce a sale within 90 days. Lazard has signaled the market.
Read full analysis → Original ↗
m&aadvisoryprivate capitallazard
MACALLAN 1926 Capital Markets May 1, 2:01 AM EDT
Seaport Therapeutics
Renaissance Capital ↗

Seaport Therapeutics prices $201M IPO for neuropsychiatric drug platform

Seaport Therapeutics, a neuropsychiatric therapeutics company, set terms for a $201 million IPO with pricing this week.

ReadingIPO biotech is back for companies with clear clinical-to-commercials pathway. Generalists with diverse pipelines stay private longer.
WatchWhether Seaport's IPO performance influences the next five preclinical biotech filing timelines.
Read full analysis → Original ↗
ipobiotechneuropsychcapital markets
LOUIS XIII Venture Intelligence May 1, 2:01 AM EDT

Avalyn heads to Nasdaq with $300M IPO for reformulated respiratory drugs

Avalyn announced plans for a $300 million IPO on Nasdaq to fund development of reformulated respiratory therapeutics.

ReadingRespiratory drug platforms can still access IPO capital if reformulation is validated. First-mover in the category locks pricing.
WatchWhether follow-on respiratory companies file in the next quarter. IPO market just validated the category.
Read full analysis → Original ↗
iporespiratorybiotechcapital markets
PAPPY 23 Technology Intelligence May 1, 2:01 AM EDT
HawkEye 360
Aviation Week ↗

HawkEye 360 details initial IPO pricing plan for RF geolocation platform

HawkEye 360, a satellite-based RF geolocation technology company, detailed its initial IPO pricing plan.

ReadingSatellite operators with government contracts can access IPO markets. Commercial space is maturing.
WatchPricing announcement and first-day trading. If the deal sizes up, follow-on space-tech companies will file within 60 days.
Read full analysis → Original ↗
iposatellitetechnologygeolocation
JOHNNIE BLUE Capital Markets May 1, 2:01 AM EDT
Crypto ETF Market
CoinDesk ↗

Bitcoin funds absorb $933M while Ethereum sees pattern outflows

Bitcoin funds recorded inflows of $933 million as crypto ETFs reached their highest assets under management since February, with XRP outperforming Ethereum.

ReadingBitcoin's institutional narrative (scarcity, macro hedge) decoupled from altcoin retail demand (yield, utility). Two markets now.
WatchWhether Ethereum inflows stabilize or continue declining. The pattern will indicate whether alt-ETF consolidation accelerates.
Read full analysis → Original ↗
cryptoetfbitcoincapital flows
WELL POUR Venture Intelligence May 1, 2:01 AM EDT
Anthropic
Seeking Alpha ↗

Anthropic's private trading values AI research firm at $1T pre-IPO

Anthropic's pre-IPO valuation reached $1 trillion in private secondary market trading, signaling investor appetite for AI research platforms.

ReadingPrivate market pricing for AI companies reflects sentiment, not fundamentals. IPO windows close when narratives get questioned.
WatchWhether Anthropic files for IPO within 12 months. The $1T whisper needs institutional validation.
Read full analysis → Original ↗
anthropicaivaluationpre-ipo